Video Staff
This is Psychedellux your weekly recap of the psychedelic industry business news
Psychedelic media company Delic Holdings Inc. (OTCQB: DELCF) has acquired mushroom kit maker and media company Homestead brands in an all-stock deal. DELIC issued subordinate voting shares worth $50,000 and 50,000 incentive stock options were also granted to Homestead founder David Tatelman, with an exercise price of $0.58. David Tatelman will act as a consultant to the company.
NeonMind Biosciences Inc. (CSE: NEON) (OTC:NMBDF) announced that they have filed four additional provisional patents on psilocybin preclinical data. NeonMind has a consumer products division focusing on medicinal mushroom infused products, as well as a pharmaceutical division focused on drug development of psychedelic compounds.
Optimi Health Corp. (CSE: OPTI) closed its oversubscribed IPO and began trading its shares last Friday on February 25, 2021 on the Canadian Securities Exchange.
Mydecine completed its harvest of psilocybin mushrooms at a private facility in Jamaica. The first shipment of the harvest has now been received at Mydecine’s Canadian facility, which has a Health Canada Schedule 1 Dealer’s License attached to it.
Novamind Inc. (OTC:NVMDF) reported its fiscal second-quarter results for the three months ended December 31, 2020. The company had revenue of $1.2 million primarily composed of patient services from the clinics in Utah. The company said it was a 47% increase over the first fiscal quarter ending September 30th, 2020.
Ehave, Inc. (OTC Pink: EHVVF) filed for a patent for a trademark on its KetaDASH brand name. The company also filed its application to uplist its shares on the OTCQB market.
Cybin Inc. (OTCQB:CLXPF) uplisted from the Pink Sheets to the OTCQB Venture Market with the symbol “CLXPF”.
